Announcements Trials
Browse Landscape

Phase

Phase 2 55Phase 1 13Phase 1/2 11Phase 3 5Phase NA 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 2Completed 2Not yet recruiting 1

Sponsor Class

INDUSTRY 17OTHER 5NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 3Rectal Neoplasms 1Neoplasms 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Diseases 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × OTHER × trifluridine tipiracil drug combination × Clear all
NCT06850090 2026-04-28

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

Shandong Cancer Hospital and Institute

Phase 3 Recruiting
210 enrolled
Gastrointestinal

Rectal Neoplasms

NCT07270991 2026-02-05

FRUQUITAS

Federation Francophone de Cancerologie Digestive

Phase 3 Recruiting
324 enrolled
Tumor-Agnostic

Neoplasms

NCT04457297 2026-01-21

ALTAIR

National Cancer Center Hospital East

Phase 3 Completed
243 enrolled 13 charts
Gastrointestinal

Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Colorectal Neoplasms

NCT03520946 2024-08-09

RAMTAS

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 3 Completed
430 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06343116 2024-04-02

NOTABLE-308

Biotech Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
420 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡